![Alan Walts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Walts
Presidente presso
ELOXX PHARMACEUTICALS, INC.
Patrimonio netto: 20 279 $ in data 30/06/2026
Profilo
Alan E.
Walts was the founder of X4 Pharmaceuticals, Inc., founded in 2013, serving as Director from 2013 to 2019.
Dr. Walts is the founder of Arrakis Therapeutics, Inc., founded in 2015, serving as Director from 2015 to 2019.
Dr. Walts is the founder of AlphaRose Therapeutics, Inc., founded in 2023, serving as Executive Chairman since 2023.
Dr. Walts is also the founder of Termeer Foundation.
Dr. Walts currently serves as Chairman & Chief Executive Officer at Aleta Biotherapeutics, Inc. Dr. Walts is Chairman at Eloxx Pharmaceuticals, Inc. since 2021.
Dr. Walts is Executive Chairman at PIC Therapeutics, Inc. since 2016.
Dr. Walts is Director at Artax Biopharma, Inc. since 2017.
Dr. Walts is Independent Director at Neuroelectrics, Inc. Dr. Walts is Venture Partner at Advent Venture Partners LLP since 2013.
Dr. Walts is Venture Partner at Advent Life Sciences LLP since 2014.
Former positions include Executive Chairman at Zikani Therapeutics, Inc. Executive Chairman at Aura Biosciences, Inc. from 2013 to 2019.
Director at Peptimmune, Inc. Managing Director at Sanofi Ventures LLC from 1986 to 2013.
Director at Proteostasis Therapeutics, Inc. Director at Valerion Therapeutics LLC.
Vice President at Genzyme Corp.
Education includes a doctorate from Massachusetts Institute of Technology conferred in 1985 and an undergraduate degree from St. John Fisher College conferred in 1981.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 09/06/2026 | 1.461 ( 3,48% ) | 20 279 $ | 30/06/2026 |
Posizioni attive di Alan Walts
| Società | Posizione | Inizio |
|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Presidente | - |
Artax Biopharma, Inc.
 Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Develops new therapies for autoimmune and inflammatory diseases | Direttore/Membro del Consiglio | - |
Neuroelectrics, Inc.
 Neuroelectrics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cloud based therapeutic platform to treat brain dysfunction | Direttore/Membro del Consiglio | - |
Termeer Foundation
 Termeer Foundation Movies/EntertainmentConsumer Services The Termeer Foundation is a nonprofit organization dedicated to empowering life science innovators and leaders to accelerate the development of transformative, patient-centered healthcare treatments. The private company is based in Boston. The foundation fosters a diverse, inclusive community of first-time CEOs, entrepreneurs, academics, and STEM students through values-driven leadership programs emphasizing responsibility, passion, creativity, humility, and connectivity. Key offerings include the Termeer Fellows Program for early-stage biotech CEOs, the Termeer Scholars Program for academic researchers translating discoveries into innovations, and support for STEM students. The foundation provides mentorship, executive coaching, strategic networking, and grants to cultivate leadership and collaboration across the life sciences sector. The American company was founded by Alan E. Walts. | Fondatore | - |
Advent Life Sciences LLP
 Advent Life Sciences LLP BiotechnologyHealth Technology Engages in production of small molecules, biologics and enabling technologies and vaccines | Corporate Officer/Principal | 01/01/2014 |
PIC Therapeutics, Inc.
 PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Presidente | 01/09/2016 |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Investitore di Private Equity | 01/01/2013 |
Aleta Biotherapeutics, Inc.
 Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cell therapy solutions for cancers and transforms cellular therapeutics to allow a broader spectrum of cancer indications | Amministratore Delegato | - |
Precedenti posizioni note di Alan Walts
| Società | Posizione | Fine |
|---|---|---|
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA-targeted small molecules on neurologic diseases, cancer and rare genetic diseases | Fondatore | 01/01/2019 |
| ░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Alan Walts
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
73
Relazioni di 1° grado
19
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 19 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Finance |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Develops new therapies for autoimmune and inflammatory diseases | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and distributes oral small molecule CXCR4 antagonists | Health Technology |
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens | Retail Trade |
Peptimmune, Inc.
 Peptimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
St. John Fisher College
 St. John Fisher College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi Ventures
 Sanofi Ventures Investment ManagersFinance Sanofi Ventures nvests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health. t provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Finance |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
Valerion Therapeutics LLC
 Valerion Therapeutics LLC Medical SpecialtiesHealth Technology Develops targeted therapies for orphan genetic diseases | Health Technology |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Engages in production of small molecules, biologics and enabling technologies and vaccines | Health Technology |
Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA-targeted small molecules on neurologic diseases, cancer and rare genetic diseases | Health Technology |
Eloxx Pharmaceuticals, Inc.
 Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
Aleta Biotherapeutics, Inc.
Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cell therapy solutions for cancers and transforms cellular therapeutics to allow a broader spectrum of cancer indications | Commercial Services |
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Neuroelectrics, Inc.
Neuroelectrics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cloud based therapeutic platform to treat brain dysfunction | Commercial Services |
Termeer Foundation
Termeer Foundation Movies/EntertainmentConsumer Services The Termeer Foundation is a nonprofit organization dedicated to empowering life science innovators and leaders to accelerate the development of transformative, patient-centered healthcare treatments. The private company is based in Boston. The foundation fosters a diverse, inclusive community of first-time CEOs, entrepreneurs, academics, and STEM students through values-driven leadership programs emphasizing responsibility, passion, creativity, humility, and connectivity. Key offerings include the Termeer Fellows Program for early-stage biotech CEOs, the Termeer Scholars Program for academic researchers translating discoveries into innovations, and support for STEM students. The foundation provides mentorship, executive coaching, strategic networking, and grants to cultivate leadership and collaboration across the life sciences sector. The American company was founded by Alan E. Walts. | Consumer Services |
